Atropine occlusion in the treatment of strabismic amblyopia and its effect upon the non-amblyopic eye.
A total of 189 cases with amblyopia, where atropine sulphate 1% had been used as a method fo unilateral occlusion, were reviewed. The results show that after atropine had been appropriately applied, permanent reversal of amblyopia is rare, and unwanted side-effects are few and of minor nature. Pupil size, light reflex and accommodation of the atropinized eye appear to be unaffected. The angle of squint was unaffected and fixation of the amblyopic eye either remained unchanged or shifted to a more central point.
North
R V
RV
Laboratory of Experimental Optometry, University of Wales, Cardiff, UK.
Kelly
M E
ME
D000550:Amblyopia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D001285:Atropine / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D008137:Longitudinal Studies; D012189:Retrospective Studies; D013285:Strabismus / Q000150:complications; D014792:Visual Acuity / Q000187:drug effects
D001285:Atropine